The patient presents with features highly suggestive of pulmonary sarcoidosis:
High-Yield (Harrison's Principles of Internal Medicine, 21st ed.): The diagnostic workup of suspected sarcoidosis mandates tissue biopsy to demonstrate non-caseating granulomas and exclude other causes. EBUS-TBNA has a diagnostic yield of >80% for mediastinal/hilar lymphadenopathy in sarcoidosis and is the preferred minimally invasive approach per ATS/ERS/WASOG guidelines.
| Option | Reasoning |
|---|---|
| A) Serum/urinary calcium | Important safety screening, but comes AFTER diagnosis is confirmed — not the immediate next step before tissue biopsy |
| B) Immediate corticosteroids | Contraindicated without tissue diagnosis, especially in a TB-endemic region |
| D) PFT and 6MWT | Useful for baseline functional assessment but secondary to establishing the diagnosis |
Suspected Sarcoidosis
↓
Tissue biopsy (EBUS-TBNA) → Non-caseating granulomas confirmed
↓
Metabolic screening (serum Ca²⁺, 24-h urinary Ca²⁺, renal function)
↓
Organ involvement assessment (PFT, DLCO, ECG, ophthalmology)
↓
Treatment decision (corticosteroids if symptomatic/progressive)| Investigation | Purpose | Timing |
|---|---|---|
| EBUS-TBNA | Histological confirmation | Immediate (next step) |
| Serum calcium, 24-h urine calcium | Hypercalcemia/hypercalciuria screening | After diagnosis confirmed |
| PFT with DLCO | Assess pulmonary function | After diagnosis confirmed |
| Ophthalmology referral | Uveitis screening | Before steroids |
| Cardiac imaging (ECG, echo) | Exclude cardiac sarcoidosis | If symptoms warrant |
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →